Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinicopathology-based Machine Learning Model for Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

NCT07426653 is registered in ClinicalTrials.gov with Florence Nightingale Hospital, Istanbul as lead sponsor.

NCT NCT07426653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07426653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinicopathology-based Machine Learning Model for Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Lead sponsor
Florence Nightingale Hospital, Istanbul
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
December 31, 2025
Enrollment
298 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer